2020, Number 1
Seroprotection for hepatitis B virus in university students of prehospital care in Cali, Colombia
Full text
Language: Spanish
References: 19
Page: 1-15
PDF size: 488.61 Kb.
ABSTRACT
Introduction: Health personnel are at risk of infectious diseases when doing their job. One of them is hepatitis B. Prehospital care students are not free from suffering this disease, especially due to the emergencies and disasters context in which they work.Objective: To determine the prevalence of seroprotection for the hepatitis B virus in prehospital care students at a university in Colombia.
Methods: Descriptive cross-sectional study carried out on prehospital care students during the period February-June 2017. No sampling technique was used because all the students in practice were included. A questionnaire was applied with questions of social-demographic data, registration of the vaccination schedule for hepatitis B and result of (Anti-HBs) antibodies. For statistical analysis, Microsoft Excel 2010 was used and descriptive statistics were designed. Numerical variables were described based on measures of central tendency and variability, categorical variables were described based on prevalence and percentage distributions.
Results: In the depiction of the 103 students who were evaluated, it was found that 98% obtained antibody titers (Anti-HBs) bigger than 10 IU/ml, being considered as reactive to the doses of the vaccines and getting protective titles. However, 93% did not fill the established vaccination schedule.
Conclusions: It can be concluded that the results obtained show the effectiveness of the applied doses of vaccine for the hepatitis B virus to obtain antibody titers to prehospital care students at a university in Colombia. But there are breaches in the recommended times for the application of each of the doses and in the time of taking the antibody titers.
REFERENCES
Villena R, Zubieta M, Hurtado C, Salgado C, Silva G, Fernández J, et al. Seroconversión frente a primovacunación reforzada contra hepatitis B en niños con cáncer. Rev. chil. pediatr. 2015 [acceso 15/10/2016];86(4):236-243. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0370- 41062015000400003&lng=es.
Sánchez Pérez MP, Velasco Benítez CA, López López P. Seroprotección para hepatitis B luego de 3 dosis de vacunación en niños colombianos menores de 18 años de edad con infección por VIH. Rev Col Gastroenterol. 2015 [acceso 06/11/2016];30(1):60-67. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120- 99572015000100009
Pessoa SD, Miyamoto M, Ono E, Gouvea A, De MoraesPinto MI, Succi R. Persistence of vaccine immunity against hepatitis B virus and response to revaccination in vertically HIV-infected adolescents on HAART. Vaccine. 2010 [acceso 15/112016];28:1606-12. Disponible en: http://www.sciencedirect.com/science/article/pii/S0264410X09018349
Cabezas Sánchez C, Trujillo Villarroel O, Zavaleta Cortijo C, Culqui Lévano D, Suarez Jara M, Cueva Maza N, et al. Prevalencia de la infección por el virus de hepatitis B en niños menores de 5 años de comunidades indígenas de la Amazonía peruana posterior a intervenciones mediante inmunización. Rev Peru Med Exp Salud Pública. 2014 [acceso 15/10/2016];31(2):204-10. Disponible en: http://www.scielo.org.pe/scielo.php?pid=S1726- 46342014000200003&script=sci_arttext
Fiestas Solórzano V, Gonzáles Noriega M, Fiestas F, Cabezudo E, Suárez M, Suárez V. Evaluación de la seroprotección contra sarampión, rubéola y hepatitis B en niños menores de cinco años del Perú, 2011. Rev Peru Med Exp Salud Pública. 2012 [20/01/2017];29(4):437-43. Disponible en: http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1726- 46342012000400004&lng=en.